Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BNMV | Common Stock | Award | +272K | +1414.22% | 292K | Aug 5, 2021 | Direct | F1, F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BNMV | Stock Options (Right to Buy) | Disposed to Issuer | +672K | 672K | Aug 5, 2021 | Common Stock | 672K | $13.00 | Direct | F3, F4 |
Id | Content |
---|---|
F1 | Represents restricted stock units ("RSUs") granted to the Reporting Person in exchange for cancellation of 672,499 stock options. The RSUs were granted under the Ecoark Holdings, Inc. 2017 Omnibus Incentive Plan (the "2017 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The grant was approved by the Compensation Committee as required by Rule 16b-3 under the Securities Exchange Act of 1934 (the "Exchange Act") and was therefore exempt from Section 16(b) of the Exchange Act. The RSUs will vest in 12 equal quarterly increments with the first vesting date being November 4, 2021, and all RSUs will immediately vest upon (i) the Reporting Person ceasing to be an employee, advisor, director or consultant for the Issuer, or (ii) upon a "change of control" of the Issuer or its wholly-owned subsidiary, Zest Labs, Inc., as defined under the 2017 Plan. |
F2 | Additionally, the Issuer agreed to grant the Reporting Person 63,998 RSUs upon the approval by the shareholders of the Issuer of an increase in the number of shares of common stock authorized for issuance under the 2017 Plan. |
F3 | On August 5, 2021, the Issuer canceled 672,499 stock options granted to the Reporting Person on October 13, 2017. In exchange for the cancelled options, the Reporting Person received 272,252 RSUs. The cancellation was approved by the Compensation Committee as required by Rule 16b-3 under the Exchange Act and was therefore exempt from Section 16(b) of the Exchange Act. |
F4 | Of the cancelled stock options (i) 403,500 stock options provided for vesting in four equal annual increments with the first such increment vesting on October 13, 2018, and (ii) 50,000 options were immediately vested as of the grant date. |